Acquisition

With a Red Hat veteran leading its go-to-market, Astronomer is betting that data orchestration is the key to unlocking enterprise AI at scale.

A new platform from cybersecurity veteran GIS QSP acts as a "flight recorder" for AI, offering cryptographic proof to unlock its use in regulated industries.

Panamanian bank Banistmo asks bondholders to amend debt rules for a fee, a key step in its billion-dollar acquisition by regional powerhouse ICC.

A landmark study reveals 100% tumor control with a personalized radiation therapy, offering profound new hope for patients with inoperable liver cancer.

Auxly Cannabis Group lost its bid for Ayurcann but secured a profitable backup role, showcasing a shrewd strategy in Canada's consolidating cannabis market.

The deal boosts Cloudcomputing's UK/US capacity by 400% and deepens its expertise in securing the next frontier: autonomous Agentic AI systems.

In a major industry shake-up, Strong Technical Services' acquisition of CinemaNext U.S. creates a dominant end-to-end provider for North America.

Ditching the old OEM model for a 'win-win ecosystem,' Chery bets on shared tech and green manufacturing. A global summit will test this bold new vision.

Italian infrastructure giant Mundys can now own nearly 30% of Getlink, a key move in European transport that passed the UK's strict security review.

AI analytics firm Analytic Edge is now a TikTok Measurement Partner, promising brands deeper, more accurate insights into their marketing performance.

Investors watch Gibson Energy closely as it prepares for its Q1 results amid mixed performance, strategic acquisitions, and a changing energy landscape.

Less than a year after its acquisition, Khoros launches Iris AI, an 'AI-native' platform aiming to unify customer engagement and unseat market leaders.

A Chicago jury found Abbott liable for infants' injuries from Similac, adding to a wave of lawsuits over the deadly intestinal disease NEC.

Gensler's Andy Cohen joins the REIT's board, signaling a strategic shift toward design-led development in LA and Honolulu's premium real estate markets.

The diagnostics firm posts strong 2025 growth, but the impending loss of a key partner puts its high-stakes strategic pivot squarely to the test.

IM Cannabis has 180 days to raise its stock price above $1.00 or risk delisting from Nasdaq, highlighting broader struggles in the global cannabis sector.

The deal with Sample Healthcare signals a major shift from managing data to using AI to execute revenue cycle tasks, tackling costs and staffing shortages.

A new AI model is beating human traders at their own game. But as EchoZ-1.0's predictions prove startlingly accurate, it raises a critical question.

A new IP firm, led by an industry veteran, acquired 500+ Avaya networking patents. The move signals a new era for tech licensing and innovation.

Lupin has launched a generic version of the blockbuster diabetes drug Farxiga, signaling lower costs for patients and a major shake-up in the SGLT2 market.